GHRP-6: What the Human Studies Actually Show
Also known as:
often mentioned with:
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
What is GHRP-6?
GHRP-6 (growth hormone-releasing peptide-6) is a synthetic six-amino-acid peptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. Cyril Bowers' lab described it in 1984 as a small peptide that released growth hormone from the pituitary in rats, monkeys and calves without releasing LH, FSH or TSH (Bowers 1984). Nobody knew which receptor it used until 1996, when that receptor was cloned and named the growth hormone secretagogue receptor (Howard 1996). Its natural key, the stomach hormone ghrelin, was found in 1999 (Kojima 1999). So GHRP-6 is best understood as an early man-made ghrelin mimic.
It is the parent of a family: GHRP-2 and hexarelin were built as stronger versions of it (Arvat 1997), and ipamorelin came out of the same chemistry later. GHRP-6 has never been approved as a medicine anywhere.
What human studies measured
The human research on GHRP-6 is small and short. It measured hormone levels over hours or days, not muscle, fat or recovery over months. Doses are left out on purpose. Last reviewed October 20, 2026.
| Study | Who | What happened |
|---|---|---|
| Bowers 1990 | 18 healthy men, single injections | Growth hormone rose with dose, and GHRP-6 plus GHRH together released more than either alone. At the highest dose, prolactin and cortisol about doubled. No adverse effects were seen |
| Frieboes 1995 | Healthy men, overnight sleep lab | Night-time growth hormone, ACTH and cortisol all rose vs placebo. Light (stage 2) sleep increased; deep slow-wave sleep did not change |
| Ghigo 1994 | 7 women aged 65 to 82, by mouth for 4 days | The growth hormone response held up after 4 days of use, but IGF-1 did not rise significantly |
| Raun 1998 | Pigs (animal study) | GHRP-6 raised ACTH and cortisol along with growth hormone; ipamorelin released growth hormone without that cortisol rise |
Why GHRP-6 makes people hungry
GHRP-6 switches on the ghrelin receptor, the same receptor the hunger hormone uses, so appetite is part of its basic action rather than a rare side effect. Hunger is the effect most associated with GHRP-6 in user discussions. The cleanest human measurement comes from its close relative GHRP-2: in a placebo-controlled infusion study every one of seven healthy men ate more at a buffet, 36% more on average (Laferrère 2005). In the original rat studies GHRP-6 also increased weight gain (Bowers 1984). That is why it shows up in bulking discussions and why it works against fat-loss goals.
Claimed benefits vs the evidence
GHRP-6 is marketed online for muscle, fat loss, recovery, sleep and healing. Here is what the research supports for each.
| Claim | What the evidence shows |
|---|---|
| Raises growth hormone | Yes, acutely, in healthy men and older adults (Bowers 1990, Ghigo 1994). A GH spike is not the same as a lasting rise in IGF-1 |
| Builds muscle | No controlled trials in healthy adults. No study has shown muscle gain from GHRP-6 |
| Burns fat | No human evidence; it increases appetite, which pushes the other way |
| Better sleep | One small study found more light sleep and no change in deep sleep (Frieboes 1995) |
| Heals injuries or protects the heart | Only animal studies, such as heart damage models in rats (Berlanga-Acosta 2024). Not tested for this in people |
Side effects and risks
In the human studies, GHRP-6 raised cortisol, ACTH and prolactin as well as growth hormone, especially at higher doses (Bowers 1990, Frieboes 1995). Hunger is expected. Longer use of oral ghrelin-receptor drugs such as MK-677 has been linked to water retention, joint and muscle aches, tingling and higher blood sugar, and the same risks are plausible for GHRP-6, but it has never been studied long term. There is no safety data beyond a few days.
Products sold online as GHRP-6 are unregulated. The FDA put GHRP-6 in Category 2 of its interim compounding policy in September 2023, the list of bulk substances that may present significant safety risks, and it stayed there after the April 2026 update. Health Canada has not authorized it, and its rules on unauthorized peptides apply. The 2026 WADA Prohibited List names GHRP-6 among GH-releasing peptides banned at all times for tested athletes.
GHRP-6 vs similar peptides
All of these act on the ghrelin receptor. Differences come from the studies linked above, not from head-to-head trials of outcomes.
| Peptide | How it differs |
|---|---|
| GHRP-2 | Built as a stronger analogue of GHRP-6; also raises cortisol and prolactin; used in Japan as a diagnostic test |
| Hexarelin | Another GHRP-6 analogue with a similar hormone profile to GHRP-2 (Arvat 1997) |
| Ipamorelin | Released growth hormone without the cortisol rise in animal testing (Raun 1998) |
| MK-677 | Not a peptide; a pill that acts on the same receptor for hours |
Anonymous GHRP-6 reports
No reports found.
If you have used GHRP-6, submit what happened, including hunger, sleep or side effects.
Submit yoursCommunity Q&A
- What does GHRP-6 do?
- It activates the ghrelin receptor, causing a short growth hormone pulse and hunger. In human studies it also raised cortisol, ACTH and prolactin.
- Does GHRP-6 build muscle?
- There are no controlled trials showing muscle gain in healthy adults. Human studies only measured hormone levels over hours to days.
- Why does GHRP-6 make you so hungry?
- It mimics ghrelin, the hunger hormone, at its receptor. A related peptide, GHRP-2, made every man in a small study eat more at a buffet.
- Is GHRP-6 FDA approved?
- No. It has been in Category 2 of the FDA interim compounding policy since September 2023 and stayed there after the April 2026 update.
- Is GHRP-6 banned in sport?
- Yes. The 2026 WADA Prohibited List bans GH-releasing peptides, naming GHRP-6, at all times.
- Is this page a GHRP-6 dosing guide?
- No. This is not a dosing recommendation.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.